โ
๐ ๐๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ
โข Revenue: $150.7M (+1% YoY)
โข GAAP EPS: -$0.15 vs. -$0.22 YoY
โข Net Loss: -$19.4M vs. -$27.5M YoY
โข Operating Loss: -$16.1M vs. -$32.2M YoY
โข Gross Margin: 75% vs. 67% YoY (+800 bps)
โข Operating Expenses: $129.0M (-3% YoY)
โข Cash & Marketable Securities: $575.7M
โ
๐ฏ ๐๐ฎ๐ข๐๐๐ง๐๐ (๐ ๐๐๐๐๐, ๐๐๐ข๐ฌ๐๐)
โข Revenue: $625Mโ$635M (prior $610Mโ$630M)
โข Revenue Growth: +4% to +6% YoY, excluding non-recurring settlement-related revenue
โ
๐ ๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
โข Gross margin expanded 800 bps, primarily from lower inventory write-downs and favorable product mix
โข Operating loss narrowed by approximately 50% YoY
โข Began global commercial shipments of Atera, reporting strong initial customer demand
โข Introduced Sentira, a cloud-based biological data analysis platform
โข Sentira uses NVIDIA accelerated computing for spatial data processing and Anthropic's Claude for agentic AI analysis of single-cell data
โข Nine-month revenue declined 5% to $452.5M
โข Nine-month net loss widened to $50.8M from $27.3M YoY
โข FY26 revenue guidance midpoint increased $10M to $630M
โข Strong liquidity provides flexibility to support new product commercialization
โ
๐ฌ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐๐ซ๐ฒ
โAs biology is entering a new era of AI and data maximalism, 10x is positioned incredibly well to benefit and to be the key enabler of progress going forward.โ - CEO Serge Saxonov
